Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: Effect of size determining formulation process variables of microparticles on the hydrodynamic diameter of BSA

References

• Arakawa T, Kita Y. Stabilizing effects of caprylate and acetyltryptophanate on heat-induced aggregation of bovine serum albumin. Biochimica Et Biophysica Acta 2000a; 1479(1–2)32–36
   PubMed Web of Science ®Google Scholar
• Arakawa T, Kita Y. Protection of bovine serum albumin from aggregation by Tween 80. Journal of Pharmaceutical Sciences 2000b; 89(5)646–651
   PubMed Web of Science ®Google Scholar
• Benjamin C. Laser light scattering: Basic principles and practice, 2nd. Academic Press, Boston 1991
   Google Scholar
• Chiti F, Taddei N, Baroni F, Capanni C, Stefani M, Ramponi G, Dobson CM. Kinetic partitioning of protein folding and aggregation. Nature Structural Biology 2002; 9(2)137–143
   PubMedGoogle Scholar
• Cleland JL, Jones AJ. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microparticles. Pharmaceutical Research 1996; 13(10)1464–1475
   PubMed Web of Science ®Google Scholar
• Cleland JL. Development of stable formulations for PLGA/PLA microparticle vaccines. Research in Immunology 1998; 149(1)45
   Google Scholar
• Corveleyn S, Remon JP. Maltodextrins as lyoprotectants in the lyophilization of a model protein, LDH. Pharmaceutical Research 1996; 13(1)146–150
   PubMed Web of Science ®Google Scholar
• Costantino HR, Langer R, Klibanov AM. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. Journal of Pharmaceutical Sciences 1994; 83(12)1662–1669
   PubMed Web of Science ®Google Scholar
• Couvreur P, Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Advanced Drug Delivery Reviews 1993; 10(2–3)141
   Web of Science ®Google Scholar
• Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microparticles target the peyer's patches. Journal of Controlled Release 1990; 11(1–3)205
   Web of Science ®Google Scholar
• Eldridge JH, Meulbroek JA, Staas JK, Tice TR, Gilley RM. Vaccine-containing biodegradable microparticles specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Advances in Experimental Medicine Biology 1989; 251: 191–202
   PubMedGoogle Scholar
• Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microparticles. Pharmaceutical Research 2000; 17(1)100–106
   PubMed Web of Science ®Google Scholar
• Hagiwara T, Kumagai H, Nakamura K. Fractal analysis of aggregates formed by heating dilute BSA solutions using light scattering methods. Bioscience Biotechnology and Biochemistry 1996; 60(11)1757–1763
   PubMed Web of Science ®Google Scholar
• Jeffery H, Davis SS, O'hagan DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles. I: Oil-in-water emulsion solvent evaporation. International Journal of Pharmaceutics 1991; 77(2–3)169
   Web of Science ®Google Scholar
• Harvey JD, Geddes R, Wills P. Conformational studies of BSA using laser light scattering. Biopolymers 1979; 18(9)2249–2260
   Web of Science ®Google Scholar
• Langer R, Cleland JL, Hanes J. New advances in microparticle-based single-dose vaccines. Advanced Drug Delivery Reviews 1997; 28(1)97–119
   PubMed Web of Science ®Google Scholar
• Marchal LM, Beeftink HH, Tramper J. Towards a rational design of commercial maltodextrins. Trends in Food Science & Technology 1999; 10(11)345
   Web of Science ®Google Scholar
• Mattison KW, Kaszuba M. Automated protein characterization. American Biotechnology Laboratory 2004; 22(13)8–11
   Google Scholar
• Peters T Jr, Feldhoff RC. Fragments of bovine serum albumin produced by limited proteolysis. Isolation and characterization of tryptic fragments. Biochemistry 1975; 14(15)3384–3391
   PubMed Web of Science ®Google Scholar
• Squire PG, Moser P, O’Konski CT. The hydrodynamic properties of bovine serum albumin monomer and dimer. Biochemistry 1968; 7(12)4261–4272
   PubMed Web of Science ®Google Scholar
• Sreerama N, Woody RW. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Analytical Biochemistry 1993; 209(1)32–44
   PubMed Web of Science ®Google Scholar
• Tamber H, Johansen P, Merkle HP, Gander B. Formulation aspects of biodegradable polymeric microparticles for antigen delivery. Advanced Drug Delivery Reviews 2005; 57(3)357
   PubMed Web of Science ®Google Scholar
• Taubes G. Misfolding the way to disease. Science 1996; 271(5255)1493–1495
   PubMed Web of Science ®Google Scholar
• Uchida T, Yagi A, Oda Y, Nakada Y, Goto S. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microparticles. Chemical and Pharmaceutical Bulletin (Tokyo) 1996; 44(1)235–236
   PubMed Web of Science ®Google Scholar
• van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly (lactic-co-glycolic acid) microparticles. Pharmacetical Research 2000; 17(10)1159–1167
   PubMed Web of Science ®Google Scholar
• van de Weert M, Hoechstetter J, Hennink WE, Crommelin DJA. The effect of a water/organic solvent interface on the structural stability of lysozyme. Journal of Controlled Release 2000; 68(3)351
   PubMed Web of Science ®Google Scholar
• Weijers RN, Bekedam DJ, Smulders YM. Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large Dutch multiethnic cohort. Diabetes Care 2002; 25(1)72–77
   PubMed Web of Science ®Google Scholar
• Youan BB, Benoit MA, Rollmann B, Riveau G, Gillard J. Protein-loaded poly(epsilon-caprolactone) microparticles. II. Muramyl dipeptide for oral controlled release of adjuvant. Journal of Microencapsulation 1999; 16(5)601–612
   PubMed Web of Science ®Google Scholar